Cefonicid Sodium

头孢尼西钠

Report date: 2023/03/20 16:04:39
NME

Base Information

Drug NameCefonicid Sodium
Drug Alias Namecefonicidum头孢尼西胺盐cefonicid头胞尼西钠头孢尼西二钠 +[8
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date2001/12/17
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAcs Dobfar SPA
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DC06